Cargando…
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance. https://bit.ly/3i43wb6
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059840/ https://www.ncbi.nlm.nih.gov/pubmed/35422426 http://dx.doi.org/10.1183/13993003.00166-2022 |
Ejemplares similares
-
Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis
por: Parums, Dinah V.
Publicado: (2021) -
The Reductionist Conundrum of an “Updated” Definition of Extensively Drug-Resistant Tuberculosis
por: Mitnick, Carole D., et al.
Publicado: (2021) -
Erectile Dysfunction: Causes, Diagnosis and Treatment: An Update
por: Mazzilli, Fernando
Publicado: (2022) -
Update on human genetic susceptibility to COVID-19: susceptibility to virus and response
por: Colona, Vito Luigi, et al.
Publicado: (2021) -
Rapid diagnosis and shorter regimen for multidrug-resistant tuberculosis: A priority to improve treatment outcome
por: Prasad, Rajendra, et al.
Publicado: (2017)